Chemotherapy-Induced Nausea and Vomiting: Incidence and Management in Jordan

Mohammad Al Qadire*

*المؤلف المقابل لهذا العمل

نتاج البحث: المساهمة في مجلةArticleمراجعة النظراء

12 اقتباسات (Scopus)

ملخص

Cancer patients experience a considerable number of symptoms during the course of their disease. Of these symptoms, chemotherapy-induced nausea and vomiting (CINV) is one of the most reported and it increases the cancer burden on patients. This study aims to assess the current status of CINV among Jordanian cancer patients, with regard to its incidence and management. A descriptive cross-sectional survey design was used. The study sample was 185 cancer patients. The mean age of participants was 46.6 years (SD = 15.5, range = 18-76) and were mainly female (56.8%). The incidence of nausea and vomiting was high at 71.4% and 57.3%, respectively. Most of the patients (89.7%) received a 5-HT3 antagonist therapy combined with corticosteroids therapy (81.1%). This study demonstrated a high incidence rate of all types of CINV, which was undertreated. Antiemetic treatment could be improved by encouraging nurses to introduce the internationally agreed guidelines into their daily clinical practice.

اللغة الأصليةEnglish
الصفحات (من إلى)730-742
عدد الصفحات13
دوريةClinical Nursing Research
مستوى الصوت27
رقم الإصدار6
المعرِّفات الرقمية للأشياء
حالة النشرPublished - يوليو 1 2018
منشور خارجيًانعم

ASJC Scopus subject areas

  • ???subjectarea.asjc.2900.2900???

بصمة

أدرس بدقة موضوعات البحث “Chemotherapy-Induced Nausea and Vomiting: Incidence and Management in Jordan'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا